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Introduction
Modified Small Bowel CT (MBCT) is a low-dose CT
method of evaluating chronic conditions affecting the small
bowel. Due to ingestion of hyperdense oral contrast, there
is resultant high contrast resolution between the bowel
lumen, bowel wall and surroundings.
This technique can be used in follow-up of chronic
conditions affecting the small bowel, including Crohn’s
disease, postoperative bowel leaks and recurrent small
bowel obstructions due to strictures and small bowel
luminal growths. MBCT is easy and comfortable for the
patient to undergo, takes a very short time to acquire
images and allows reconstruction of images in any plane by
the radiologist during post-processing.
Description of technique
Compared with fluoroscopic small bowel enteroclysis or
CT enteroclysis, MBCT is non-invasive and less time-
consuming for radiologists, since there is no need for
duodenal intubation or spot imaging at the time of image
acquisition. It does not use intravenous dye and therefore is
safer for the patient and less expensive than CT enterography
or standard contrast-enhanced CT scans.
As part of the MBCT protocol, patients fast for 6 hours
prior to the exam. No bowel preparation or nasogastric tube
insertion is needed. An oral solution of 9% Telebrix-38
(meglumine ioxitalamate; Tyco healthcare, Quebec, Canada)
is administered rather than 3% used for most standard CT
scans of the abdomen and pelvis. This oral contrast has a high
attenuation (500 to 600 HU), increasing contrast resolution on
this unenhanced CT protocol. Denser oral contrast cannot be
used as it would cause beam hardening artifacts. Patients drink
300 ml aliquots of 9% of oral contrast every 15 minutes over
60 minutes, for a total volume of 1200 ml. The isotonic nature
of the 9% oral contrast gives better distension of the bowel
lumen compared to water or other lower osmolal solutions,
since there is physiologically less absorption of the isotonic
solution by the small bowel. The hyperdense oral contrast is
visible on scout images, thus when it is seen in the ascending
colon, this indicates satisfactory opacification of the small
bowel. A Noise Index of 28 is used with Auto-mAmodulation
on 16 or 64-slice scanners (GE Lightspeed, VCT LightSpeed
(Germany)) compared to a typical noise index of 12–18 for a
standard abdominopelvic CT scan. Image noise (GE Health-
care, noise index [NI]) is an operator-selected variable which
alters the range of mA over which an automated tube current
modulation varies during gantry rotation. In this way, one can
produce a selected level of average noise in an image [1]. This
higher noise index can be used in of the MBCT because
there is inherent high contrast between the hyperdense oral
contrast used in this CT protocol, and the bowel wall. The
combination of high Noise Index and Auto-mA modulation
reduces patient radiation dose. Remaining parameters include
120 kV, mA range of 100 to 240 mA, a 0.5 sec gantry
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rotation and a pitch of 1, with slice reconstruction of 0.5 to
1.25 mm, depending on the scanner used. Prone and supine
scanning ensures opacification of all parts of the small bowel,
but at the discretion of the radiologist, the prone scan can be
omitted, particularly in follow-up studies. Images are viewed
at a window of 800–900 HU and level of 200-300 HU.
Radiation dose from a supine acquisition with the above
parameters have a dose length product (DLP) of 150
mGycm, which equates to approximately 2.55 mSv ( range
1.57–5.23 mSv) This is calculated using the formula for
estimated radiation exposure E = DLP x 0.015 (abdominal
conversion factor) [2]. Barium procedures such as SBFT
and enteroclysis have been reported to have effective doses
of 13.68 ± 6.85 mSv and 13.99 ± 7.57 mSv respectively
[3]. CT enterography mean effective doses have also been
reported at 9.58 mSv, with additional 1.13 mSv for the
placement of the nasojejunal tube [4].
Reconstructed thin slices are post-processed to produce
maximum intensity projections (MIP), multiplanar reformats
(MPR), and virtual endoscopy images, which have been
shown to increase diagnostic confidence [5, 6]. On average
reconstructions take less than 5 minutes, but may require up
to 20 minutes, depending on the case’s complexity.
Discussion
With increasing concerns about patient radiation exposure
from medical imaging, the development of low-radiation CT
protocols is of value. This has been employed for renal stone
evaluation, diagnosing suspected diverticulitis and for lung
nodule follow-up [7, 8, 9]. The good spatial resolution, high
contrast resolution, fast image acquisition and multi-planar
reconstruction capabilities of computed tomography make
this imaging modality very attractive for imaging the bowel
as well. MRI and sonography are other imaging techniques
that do not expose patients to ionizing radiation that can also
be used to evaluate the bowel. Although MRI does not use
radiation and has excellent contrast resolution, it is not as
easily accessible, it requires the use of intravenous contrast,
and the fairly long scan times can affect image quality
because of intrinsic peristalsis of the small bowel [10].
Sonography can depict areas of bowel wall thickening
and areas of inflammation; however, there are limitations,
such as operator dependence, inter-observer agreement and
even intra-observer agreement in the same patient during
follow-up imaging. Additionally, detection and character-
ization of complex entero-enteric fistulas can be difficult
[11]. Thus, we have developed a low-radiation dose,
modified bowel CT (MBCT) enterography technique using
hyperdense oral contrast, without intravenous contrast.
MBCT can specifically evaluate small bowel while expos-
ing the patient to less radiation compared to SBFT and CT
enterography [4]. MBCT can characterize small bowel-
related abnormalities, such as hernias, acute versus chronic
Crohn’s disease, postoperative fistulas or bowel leaks and
small bowel intraluminal masses including the site of
chronic, low-grade bowel obstructions.
Applications
Follow-up of Crohn’s disease
Active Crohn’s disease on CT enterography is identified by
increased mural attenuation, increased mural thickness, mural
stratification and vasa recta hypervascularity [12, 13]. On
SBFT, there is luminal narrowing with irregularity, but
differentiation from chronic disease is not always possible
[14]. On MBCT, increased mural thickness, increased
mesenteric fat attenuation and prominent vasa recta can be
identified, indicating active disease (Fig. 1). MBCT imaging
for Crohn’s disease can delineate extraluminal complications
such as fluid collections and enterocutaneous/enteroenteric
fistulas. MBCT can also identify widening and fatty
infiltration of the submucosal layer of the bowel due to
chronic inflammation, consistent with the fat-halo sign [15].
Extra-enteric abnormalities associated with Crohn’s disease,
including gallstones, renal stones and sacroiliitis, can often
be identified.
Small bowel hernias
Abdominal hernias are evaluated using MBCT, especially
with provocation techniques such as Valsalva manoeuvres,
to enhance visualisation of the area of herniation.
Fig. 1 A 38-year-old with Crohn’s disease. There is mural thickening
of the ileum (black arrows), increased mesenteric fat attenuation and
prominence of the vasa recta (white arrowhead), all in keeping with
active disease superimposed on previously documented chronic
thickening of the ileum
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Post-operative small bowel leaks/fistulas
Compared with fluoroscopic techniques, MBCT is advanta-
geous in the assessment of enteric fistulas because of its ability
to define the cross-sectional location of the underlying disease
(Fig. 2a, b).
Chronic low-grade obstructions
Modified bowel CT is useful in identifying chronic low-
grade obstructions, including the dilated segment and
location of obstruction. Often, the diagnosis is that of
adhesions, with abnormal tethering of small bowel loops
and an associated distinct transition point indicating the site
of obstruction. Strictures can also be characterised, including
the length of bowel involvement and the severity of luminal
narrowing.
Small bowel tumours
Small bowel neoplasms can be identified as a filling defect
or an area of narrowing on MBCT. MBCT can depict areas
of irregular luminal narrowing and shouldering of the
margins, raising the suspicion of an underlying malignancy
(Fig. 3a, b). Extrinsic masses, such as adenopathy and
abnormal mesenteric masses, are also identifiable on
MBCT.
Limitations
This technique is not recommended for evaluating patients
with non-specific abdominal pain, unexplained weight loss
or possible metastatic disease. As MBCT does not use
intravenous contrast material, solid organs cannot be
adequately evaluated. Differentiating a phlegmon from a
mature abscess can be challenging without the use of
intravenous contrast material. This technique should not be
Fig. 3 A 94-year-old man with a mass suspected on standard CT
underwent MBCT, which demonstrated a mass in the third part of the
duodenum and luminal narrowing (a). Volume rendering demonstrates
the narrowing of the bowel lumen and “shouldering” appearance of
the mass (b). Endoscopy with biopsies confirmed an adenomatous
polypoid lesion with foci of high-grade dysplasia
Fig. 2 A 46-year-old woman underwent Whipple's surgery for
pancreatic cancer and presented with a draining sinus. A conventional
fistulogram was performed demonstrating the fistula tract (black
arrow) communicating with a jejunal loop, but further characterisation
was difficult secondary to overlapping structures (a). MBCT demon-
strates the complex nature of the fistula, with branching sinus tracts
and two connections to the afferent jejunal loop (white arrows) (b)
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used in acute GI bleeding since the hyperdense oral contrast
will obscure visualisation of the luminal blood.
Conclusion
Amid increasing concerns about radiation exposure in
patients, MBCT is a safe, simple and practical way to
evaluate the small bowel specifically. This technique uses
less radiation then CTE or SBFT, and images can be
reconstructed in any plane, obviating SBFT limitations of
overlapping bowel loops and reducing risks by eliminating
intravenous contrast material administration. The goal of
developing MBCT is to replace SBFT; a direct comparison
of MBCT with SBFT, with surgical outcomes and imaging
follow-up, is planned for evaluating specific small bowel
abnormalities, including recurrent symptoms of established
Crohn’s disease and for the evaluation of hernias.
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